StockData
Sanara MedTech Inc. logo

Sanara MedTech Inc. (SMTI) stock

SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73+0.00 (0.00%)

Close on Nov 18, 2026Market cap $300.72MP/E –Yield –

Earnings

Sanara MedTech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$28.40M
+8.0% on a year earlier
EPS, Q3 FY2026
-$0.15
-$3.40 a year earlier
Latest guidance
Lowered
Nov 12, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Sanara MedTech's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close$28.40M+8.0%-$0.15Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 11, 2026after the close$27.80M–$0.05Release
Q4 FY2025ended Dec 31, 2025Mar 24, 2026before the open$27.50M+4.6%-$0.19Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$26.30M+21.2%-$3.40Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025before the open$25.80M+27.7%–Release
Q1 FY2025ended Mar 31, 2025May 14, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025before the open$26.30M+48.6%-$0.18Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$21.70M+35.6%–Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024after the close$20.20M+27.8%-$0.41Release
Q1 FY2024ended Mar 31, 2024May 13, 2024before the open$18.50M+19.4%-$0.21Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Sanara MedTech's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
growthFY2026+13% – +17%–NewMay 11, 2026
net revenueFY2026$110.00M – $115.00M$116.00M – $121.00MLoweredNov 12, 2026
net revenueFY2026$116.00M – $121.00M–NewMay 11, 2026
net revenueGAAPFY2026$116.00M – $121.00M–NewJan 23, 2026

Guidance history

Every forecast Sanara MedTech put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 12, 2026net revenueFY2026$110.00M – $115.00MLowered
May 11, 2026R&Dannual basis5% – 7%–
May 11, 2026growthQ2 FY2026+10% – +14%New
May 11, 2026net revenueFY2026$116.00M – $121.00MNew
May 11, 2026growthFY2026+13% – +17%New
May 11, 2026net revenueQ2 FY2026$28.50M – $29.50MNew
Mar 24, 2026net revenueFY2026$116.00M – $121.00MNew
Jan 23, 2026net revenueFY2026$116.00M – $121.00MNew
Nov 12, 2025total cash investment in THPFY2025$5.50M – $6.50MReaffirmed
Aug 13, 2025cash investment during the second half of 2025FY2025$5.50M – $6.50MLowered
Mar 25, 2025continued investment in Tissue Health PlusFY2025$7.50M – $10.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Sanara MedTech filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Results
  6. Update
  7. Results
  8. Update
  9. Results
  10. Results
  11. Update
  12. Results
  13. Update
  14. Results
  15. Update

See a number that looks wrong?